Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 17, 2021 - Issue 5
Submit an article Journal homepage
1,405
Views
1
CrossRef citations to date
0
Altmetric
Research Paper

Bactericidal antibodies against hypervirulent Neisseria meningitidis C field strains following MenC-CRM or MenACWY-CRM priming and MenACWY-CRM booster in children

Marzia Monica Giuliania Preclinical Evidence Generation, GSK, Siena, ItalyORCID Iconhttps://orcid.org/0000-0002-6530-5951View further author information
ORCID Icon,
Alessia Biolchia Preclinical Evidence Generation, GSK, Siena, ItalyView further author information
,
Pavitra Keshavanc Clinical Research and Development, GSK, Siena, ItalyView further author information
,
Maria Moriondoe Department of Health Sciences, University of Florence and Meyer Children’s University Hospital, Florence, ItalyORCID Iconhttps://orcid.org/0000-0001-9653-8371View further author information
ORCID Icon,
Sara Tomeia Preclinical Evidence Generation, GSK, Siena, ItalyORCID Iconhttps://orcid.org/0000-0002-5136-6876View further author information
ORCID Icon,
Laura Santinia Preclinical Evidence Generation, GSK, Siena, ItalyORCID Iconhttps://orcid.org/0000-0002-9638-7275View further author information
ORCID Icon,
Elena Moria Preclinical Evidence Generation, GSK, Siena, ItalyORCID Iconhttps://orcid.org/0000-0003-4697-9333View further author information
ORCID Icon,
Alessandro Brozzib Data Science and Digital Innovation, GSK, Siena, ItalyView further author information
,
Margherita Bodinib Data Science and Digital Innovation, GSK, Siena, ItalyORCID Iconhttps://orcid.org/0000-0002-7054-8712View further author information
ORCID Icon,
Francesco Nieddue Department of Health Sciences, University of Florence and Meyer Children’s University Hospital, Florence, ItalyORCID Iconhttps://orcid.org/0000-0003-4460-3631View further author information
ORCID Icon,
Silvia Riccie Department of Health Sciences, University of Florence and Meyer Children’s University Hospital, Florence, ItalyView further author information
,
Thembile Mzolof Biostat and Statistical Programming, GSK, Amsterdam, The NetherlandsView further author information
,
Marco Costantinid Biostat and Statistical Programming, GSK, Siena, ItalyORCID Iconhttps://orcid.org/0000-0003-4709-2590View further author information
ORCID Icon,
Chiara Azzarie Department of Health Sciences, University of Florence and Meyer Children’s University Hospital, Florence, ItalyORCID Iconhttps://orcid.org/0000-0001-7236-1655View further author information
ORCID Icon &
Michele Pellegrinic Clinical Research and Development, GSK, Siena, ItalyCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-8505-9260View further author information
ORCID Icon show all
Pages 1442-1449 | Received 10 Jul 2020, Accepted 03 Oct 2020, Published online: 16 Dec 2020

References

  • Stefanelli P, Miglietta A, Pezzotti P, Fazio C, Neri A, Vacca P, Voller F, D’Ancona FP, Guerra R, Iannazzo S, et al. Increased incidence of invasive meningococcal disease of serogroup C/clonal complex 11, Tuscany, Italy, 2015 to 2016. Euro Surveill. 2016;21(12). doi:10.2807/1560-7917.ES.2016.21.12.30176.
  • Summary of product characteristics. Menjugate. [accessed 2020 Feb 10]. http://gskpro.com/content/dam/global/hcpportal/en_MT/PDF/Homepage/Products/productlisting/menjugate/Menjugate%20spc.pdf.
  • European Medicines Agency. Summary of product characteristics. Menveo. [accessed 2020 Feb 10]. http://www.ema.europa.eu/en/documents/product-information/menveo-epar-product-information_en.pdf.
  • Jolley KA, Bray JE, Maiden MCJ. Open-access bacterial population genomics: BIGSdb software, the PubMLST.org website and their applications. Wellcome Open Res. 2018;3:124. doi:10.12688/wellcomeopenres.14826.1.
  • Jolley KA, Maiden MC. BIGSdb: scalable analysis of bacterial genome variation at the population level. BMC Bioinform. 2010;11:595. doi:10.1186/1471-2105-11-595.
  • Bratcher HB, Corton C, Jolley KA, Parkhill J, Maiden MC. A gene-by-gene population genomics platform: de novo assembly, annotation and genealogical analysis of 108 representative Neisseria meningitidis genomes. BMC Genomics. 2014;15(1):1138. doi:10.1186/1471-2164-15-1138.
  • Huson DH, Bryant D. Application of phylogenetic networks in evolutionary studies. Mol Biol Evol. 2006;23(2):254–67. doi:10.1093/molbev/msj030.
  • Borrow R, Aaberge IS, Santos GF, Eudey TL, Oster P, Glennie A, Findlow J, Hoiby EA, Rosenqvist E, Balmer P, et al. Interlaboratory standardization of the measurement of serum bactericidal activity by using human complement against meningococcal serogroup B, strain 44/76-SL, before and after vaccination with the Norwegian MenBvac outer membrane vesicle vaccine. Clin Diagn Lab Immunol. 2005;12(8):970–76. doi:10.1128/CDLI.12.8.970-976.2005.
  • Snape MD, Perrett KP, Ford KJ, John TM, Pace D, Yu LM, Langley JM, McNeil S, Dull PM, Ceddia F, et al. Immunogenicity of a tetravalent meningococcal glycoconjugate vaccine in infants: a randomized controlled trial. JAMA. 2008;299(2):173–84. doi:10.1001/jama.2007.29-c.
  • Vu DM, Welsch JA, Zuno-Mitchell P, Dela Cruz JV, Granoff DM. Antibody persistence 3 years after immunization of adolescents with quadrivalent meningococcal conjugate vaccine. J Infect Dis. 2006;193(6):821–28. doi:10.1086/500512.
  • Pezzotti P, Miglietta A, Neri A, Fazio C, Vacca P, Voller F, Rezza G, Stefanelli P. Meningococcal C conjugate vaccine effectiveness before and during an outbreak of invasive meningococcal disease due to Neisseria meningitidis serogroup C/cc11, Tuscany, Italy. Vaccine. 2018;36(29):4222–27. doi:10.1016/j.vaccine.2018.06.002.
  • Goldschneider I, Gotschlich EC, Artenstein MS. Human immunity to the meningococcus. I. The role of humoral antibodies. J Exp Med. 1969;129(6):1307–26. doi:10.1084/jem.129.6.1307.
  • McIntosh ED, Broker M, Wassil J, Welsch JA, Borrow R. Serum bactericidal antibody assays - The role of complement in infection and immunity. Vaccine. 2015;33(36):4414–21. doi:10.1016/j.vaccine.2015.07.019.
  • Borrow R, Balmer P, Miller E. Meningococcal surrogates of protection-Serum bactericidal antibody activity. Vaccine. 2005;23(17–18):2222–27. doi:10.1016/j.vaccine.2005.01.051.
  • Frasch CE, Borrow R, Donnelly J. Bactericidal antibody is the immunologic surrogate of protection against meningococcal disease. Vaccine. 2009;27(Suppl 2):B112–116. doi:10.1016/j.vaccine.2009.04.065.
  • Plotkin SA. Correlates of protection induced by vaccination. Clin Vaccine Immunol. 2010;17(7):1055–65. doi:10.1128/cvi.00131-10.
  • Findlow H, Plikaytis BD, Aase A, Bash MC, Chadha H, Elie C, Laher G, Martinez J, Herstad T, Newton E, et al. Investigation of different group A immunoassays following one dose of meningococcal group A conjugate vaccine or A/C polysaccharide vaccine in adults. Clin Vaccine Immunol. 2009;16(7):969–77. doi:10.1128/cvi.00068-09.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.